Gregor Fuhrmann
Gregor Fuhrmann
Junior Research Group Leader Helmholtz Institute for Pharmaceutical Research
Bestätigte E-Mail-Adresse bei helmholtz-hzi.de - Startseite
TitelZitiert vonJahr
Sustained gastrointestinal activity of dendronized polymer–enzyme conjugates
G Fuhrmann, A Grotzky, R Lukić, S Matoori, P Luciani, H Yu, B Zhang, ...
Nature chemistry 5 (7), 582, 2013
622013
Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins
G Fuhrmann, A Serio, M Mazo, R Nair, MM Stevens
Journal of Controlled Release 205, 35-44, 2015
612015
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer’s disease
G Bastiat, F Plourde, A Motulsky, A Furtos, Y Dumont, R Quirion, ...
Biomaterials 31 (23), 6031-6038, 2010
592010
The copolymer P (HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues
M Pinier, G Fuhrmann, HJ Galipeau, N Rivard, JA Murray, CS David, ...
Gastroenterology 142 (2), 316-325. e12, 2012
542012
Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges
G Fuhrmann, IK Herrmann, MM Stevens
Nano Today 10 (3), 397-409, 2015
422015
Prevention measures and exploratory pharmacological treatments of celiac disease
M Pinier, G Fuhrmann, E Verdu, JC Leroux
The American journal of gastroenterology 105 (12), 2551, 2010
322010
In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract
G Fuhrmann, JC Leroux
Proceedings of the National Academy of Sciences 108 (22), 9032-9037, 2011
282011
Improving the Stability and Activity of Oral Therapeutic Enzymes—Recent Advances and Perspectives
G Fuhrmann, JC Leroux
Pharmaceutical research 31 (5), 1099-1105, 2014
242014
Extracellular stiffness modulates the expression of functional proteins and growth factors in endothelial cells
L Santos, G Fuhrmann, M Juenet, N Amdursky, CM Horejs, ...
Advanced healthcare materials 4 (14), 2056-2063, 2015
172015
Celiac disease: a challenging disease for pharmaceutical scientists
S Matoori, G Fuhrmann, JC Leroux
Pharmaceutical research 30 (3), 619-626, 2013
162013
Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
G Fuhrmann, R Chandrawati, PA Parmar, TJ Keane, SA Maynard, ...
Advanced Materials 30 (15), 1706616, 2018
122018
extracellular vesicles–A promising avenue for the detection and treatment of infectious diseases?
G Fuhrmann, AL Neuer, IK Herrmann
European Journal of Pharmaceutics and Biopharmaceutics 118, 56-61, 2017
122017
Recent advances in oral delivery of macromolecular drugs and benefits of polymer conjugation
K Fuhrmann, G Fuhrmann
Current Opinion in Colloid & Interface Science 31, 67-74, 2017
102017
Biogenic and biomimetic carriers as versatile transporters to treat infections
A Goes, G Fuhrmann
ACS infectious diseases, 2018
52018
In vitro evaluation of the stability of proline-specific endopeptidases under simulated gastrointestinal conditions
G Fuhrmann, JC Leroux
Journal of Controlled Release 148 (1), e37-e39, 2010
32010
Experimental therapies for celiac disease
G Fuhrmann
PHARMAKON 6 (2), 132-139, 2018
12018
Drug Delivery: Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy (Adv. Mater. 15/2018)
G Fuhrmann, R Chandrawati, PA Parmar, TJ Keane, SA Maynard, ...
Advanced Materials 30 (15), 1870109, 2018
2018
Corrigendum: Sustained gastrointestinal activity of dendronized polymer–enzyme conjugates
G Fuhrmann, A Grotzky, R Lukić, S Matoori, P Luciani, H Yu, B Zhang, ...
Nature chemistry 8 (3), 281, 2016
2016
Polymer–Enzyme Conjugates for Oral Drug Delivery Applications
G Fuhrmann, MA Gauthier, JC Leroux
CHIMIA International Journal for Chemistry 67 (9), 685-685, 2013
2013
Stability of gluten-cleaving enzymes in the gastrointestinal tract
G Fuhrmann
ETH Zurich, 2013
2013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20